{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:04:10Z","timestamp":1793037850584,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04105-8","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T03:29:36Z","timestamp":1752722976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Efficacy\u00a0and safety of fecal microbiota transplantation in\u00a0the management of parkinson\u2019s disease:\u00a0a systematic review"],"prefix":"10.1186","volume":"25","author":[{"given":"Yehia","family":"Nabil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Mohsen","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israa Ahmed","family":"Qutob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I. Abbas","family":"Dawoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roaa","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaida Majid","family":"Manasrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa M.","family":"AlEdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadi","family":"Sleibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayhan","family":"faris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr K.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Nandwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"4105_CR1","doi-asserted-by":"publisher","unstructured":"Aho, V.T.E. et al. (2019) \u2018Gut microbiota in Parkinson\u2019s disease: Temporal stability and relations to disease progression\u2019, EBioMedicine, 44, pp. 691\u2013707. Available at: https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.064.","DOI":"10.1016\/j.ebiom.2019.05.064"},{"key":"4105_CR2","doi-asserted-by":"publisher","unstructured":"Aho, V.T.E. et al. (2021) \u2018Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease\u2019, Molecular Neurodegeneration, 16(1), pp. 1\u201314. Available at: https:\/\/doi.org\/10.1186\/S13024-021-00427-6\/FIGURES\/7.","DOI":"10.1186\/S13024-021-00427-6\/FIGURES\/7"},{"key":"4105_CR3","doi-asserted-by":"publisher","unstructured":"Beliz\u00e1rio, J.E., Faintuch, J. and Garay-Malpartida, M. (2018) \u2018Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases\u2019, Mediators of Inflammation, 2018, p. 2037838. Available at: https:\/\/doi.org\/10.1155\/2018\/2037838.","DOI":"10.1155\/2018\/2037838"},{"key":"4105_CR4","doi-asserted-by":"publisher","unstructured":"Boertien, J.M. et al. (2022) \u2018Fecal microbiome alterations in treatment-naive de novo Parkinson\u2019s disease\u2019, npj Parkinson\u2019s Disease 2022 8:1, 8(1), pp. 1\u201312. Available at: https:\/\/doi.org\/10.1038\/s41531-022-00395-8.","DOI":"10.1038\/s41531-022-00395-8"},{"key":"4105_CR5","doi-asserted-by":"publisher","unstructured":"Bove, C. and Travagli, R.A. (2019) \u2018Neurophysiology of the brain stem in Parkinson\u2019s disease\u2019, J neurophysiol, 121(5), pp. 1856\u20131864. Available at: https:\/\/doi.org\/10.1152\/JN.00056.2019.","DOI":"10.1152\/JN.00056.2019"},{"key":"4105_CR6","doi-asserted-by":"publisher","unstructured":"Braak, H. et al. (2003) \u2018Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen\u2019, J neural trans (Vienna, Austria\u202f: 1996), 110(5), pp. 517\u2013536. Available at: https:\/\/doi.org\/10.1007\/S00702-002-0808-2.","DOI":"10.1007\/S00702-002-0808-2"},{"key":"4105_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/J.ECLINM.2024.102563","author":"A Bruggeman","year":"2024","unstructured":"Bruggeman A, et al. \u2018Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson\u2019s disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial\u2019, EClinicalMedicine, 71. Available at: 2024. https:\/\/doi.org\/10.1016\/J.ECLINM.2024.102563.","journal-title":"Available at:"},{"key":"4105_CR8","doi-asserted-by":"publisher","unstructured":"Burke, R.E., Dauer, W.T. and Vonsattel, J.P.G. (2008) \u2018A critical evaluation of the Braak staging scheme for Parkinson\u2019s disease\u2019, Ann neurol, 64(5), pp. 485\u2013491. Available at: https:\/\/doi.org\/10.1002\/ANA.21541.","DOI":"10.1002\/ANA.21541"},{"key":"4105_CR9","doi-asserted-by":"publisher","unstructured":"Camacho, M. et al. (2021) \u2018Early constipation predicts faster dementia onset in Parkinson\u2019s disease\u2019, npj Parkinson\u2019s Disease 2021 7:1, 7(1), pp. 1\u20137. Available at: https:\/\/doi.org\/10.1038\/s41531-021-00191-w.","DOI":"10.1038\/s41531-021-00191-w"},{"key":"4105_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2284247","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, et al. \u2018Efficacy of fecal microbiota transplantation in patients with Parkinson\u2019s disease: clinical trial results from a randomized, placebo-controlled design\u2019, Gut microbes, 15(2). Available at: 2023. https:\/\/doi.org\/10.1080\/19490976.2023.2284247.","journal-title":"Available at:"},{"key":"4105_CR11","doi-asserted-by":"publisher","unstructured":"Cherbut, C. et al. (1997) \u2018Effects of short-chain fatty acids on gastrointestinal motility\u2019, Scandinavian journal of gastroenterology. Supplement, 222(222), pp. 58\u201361. Available at: https:\/\/doi.org\/10.1080\/00365521.1997.11720720.","DOI":"10.1080\/00365521.1997.11720720"},{"key":"4105_CR12","doi-asserted-by":"publisher","unstructured":"Cilia, R. et al. (2021) \u2018Does Gut Microbiota Influence the Course of Parkinson\u2019s Disease? A 3-Year Prospective Exploratory Study in de novo Patients\u2019, J Parkinson\u2019s Dis, 11(1), pp. 159\u2013170. Available at: https:\/\/doi.org\/10.3233\/JPD-202297.","DOI":"10.3233\/JPD-202297"},{"key":"4105_CR13","doi-asserted-by":"publisher","unstructured":"Dempsey, E. and Corr, S.C. (2022) \u2018Lactobacillus spp. for Gastrointestinal Health: Current and Future Perspectives\u2019, Front Immunol, 13. Available at: https:\/\/doi.org\/10.3389\/FIMMU.2022.840245\/PDF.","DOI":"10.3389\/FIMMU.2022.840245\/PDF"},{"key":"4105_CR14","doi-asserted-by":"publisher","unstructured":"Devos, D. et al. (2013) \u2018Colonic inflammation in Parkinson\u2019s disease\u2019, Neurobiol dis, 50(1), pp. 42\u201348. Available at: https:\/\/doi.org\/10.1016\/J.NBD.2012.09.007.","DOI":"10.1016\/J.NBD.2012.09.007"},{"key":"4105_CR15","doi-asserted-by":"publisher","unstructured":"Ding, X. et al. (2019) \u2018Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis\u2019, Drug safety, 42(7), pp. 869\u2013880. Available at: https:\/\/doi.org\/10.1007\/S40264-019-00809-2.","DOI":"10.1007\/S40264-019-00809-2"},{"key":"4105_CR16","doi-asserted-by":"publisher","unstructured":"Drossman, D.A. (2016) \u2018Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV\u2019, Gastroenterology, 150(6), pp. 1262\u20131279.e2. Available at: https:\/\/doi.org\/10.1053\/J.GASTRO.2016.02.032.","DOI":"10.1053\/J.GASTRO.2016.02.032"},{"key":"4105_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/FNEUR.2023.1104759\/PDF","author":"HL DuPont","year":"2023","unstructured":"DuPont HL, et al. \u2018Fecal microbiota transplantation in Parkinson\u2019s disease\u2014A randomized repeat-dose, placebo-controlled clinical pilot study\u2019, Front Neurol, 14. Available at: 2023. https:\/\/doi.org\/10.3389\/FNEUR.2023.1104759\/PDF.","journal-title":"Available at:"},{"key":"4105_CR18","doi-asserted-by":"publisher","unstructured":"Erny, D. et al. (2015) \u2018Host microbiota constantly control maturation and function of microglia in the CNS\u2019, Nat neurosci, 18(7), pp. 965\u2013977. Available at: https:\/\/doi.org\/10.1038\/NN.4030.","DOI":"10.1038\/NN.4030"},{"key":"4105_CR19","doi-asserted-by":"publisher","unstructured":"Goetz, C.C. (2003) \u2018The Unified Parkinson\u2019s Disease Rating Scale (UPDRS): status and recommendations\u2019, Movement disorders\u202f: official journal of the Movement Disorder Society, 18(7), pp. 738\u2013750. Available at: https:\/\/doi.org\/10.1002\/MDS.10473.","DOI":"10.1002\/MDS.10473"},{"key":"4105_CR20","doi-asserted-by":"publisher","unstructured":"Goetz, C.G. et al. (2008) \u2018Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results\u2019, Movement disorders\u202f: official journal of the Movement Disorder Society, 23(15), pp. 2129\u20132170. Available at: https:\/\/doi.org\/10.1002\/MDS.22340.","DOI":"10.1002\/MDS.22340"},{"key":"4105_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0205064","author":"ZD Jiang","year":"2018","unstructured":"Jiang ZD, et al. \u2018Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial\u2019, PloS one, 13(11). Available at: 2018. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0205064.","journal-title":"Available at:"},{"key":"4105_CR22","doi-asserted-by":"publisher","unstructured":"Kim, N. et al. (2021) \u2018Transplantation of gut microbiota derived from Alzheimer\u2019s disease mouse model impairs memory function and neurogenesis in C57BL\/6 mice\u2019, Brain, behavior, and immu, 98, pp. 357\u2013365. Available at: https:\/\/doi.org\/10.1016\/J.BBI.2021.09.002.","DOI":"10.1016\/J.BBI.2021.09.002"},{"key":"4105_CR23","doi-asserted-by":"publisher","unstructured":"Kuai, X. yi et al. (2021) \u2018Evaluation of fecal microbiota transplantation in Parkinson\u2019s disease patients with constipation\u2019, Micro Cell Factories, 20(1), pp. 1\u20139. Available at: https:\/\/doi.org\/10.1186\/S12934-021-01589-0\/FIGURES\/3.","DOI":"10.1186\/S12934-021-01589-0\/FIGURES\/3"},{"key":"4105_CR24","doi-asserted-by":"publisher","unstructured":"Lach, G. et al. (2018) \u2018Anxiety, Depression, and the Microbiome: A Role for Gut Peptides\u2019, Neurotherapeutics\u202f: the journal of the American Society for Experimental NeuroTherapeutics, 15(1), pp. 36\u201359. Available at: https:\/\/doi.org\/10.1007\/S13311-017-0585-0.","DOI":"10.1007\/S13311-017-0585-0"},{"key":"4105_CR25","doi-asserted-by":"publisher","unstructured":"Leite Silva, A.B.R. et al. (2023) \u2018Premotor, nonmotor and motor symptoms of Parkinson\u2019s Disease: A new clinical state of the art\u2019, Ageing Research Reviews, 84, p. 101834. Available at: https:\/\/doi.org\/10.1016\/J.ARR.2022.101834.","DOI":"10.1016\/J.ARR.2022.101834"},{"key":"4105_CR26","doi-asserted-by":"publisher","unstructured":"Ley, R.E., Peterson, D.A. and Gordon, J.I. (2006) \u2018Ecological and evolutionary forces shaping microbial diversity in the human intestine\u2019, Cell, 124(4), pp. 837\u2013848. Available at: https:\/\/doi.org\/10.1016\/J.CELL.2006.02.017.","DOI":"10.1016\/J.CELL.2006.02.017"},{"key":"4105_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/FNMOL.2019.00171\/PDF","author":"C Li","year":"2019","unstructured":"Li C, et al. \u2018Gut microbiota differs between parkinson\u2019s disease patients and healthy controls in northeast China\u2019, Frontiers in Molecular Neuroscience, 12. Available at: 2019. https:\/\/doi.org\/10.3389\/FNMOL.2019.00171\/PDF.","journal-title":"Available at:"},{"key":"4105_CR28","doi-asserted-by":"publisher","unstructured":"Li, N. et al. (2019) \u2018Fecal microbiota transplantation from chronic unpredictable mild stress mice donors affects anxiety-like and depression-like behavior in recipient mice via the gut microbiota-inflammation-brain axis\u2019, Stress (Amsterdam, Netherlands), 22(5), pp. 592\u2013602. Available at: https:\/\/doi.org\/10.1080\/10253890.2019.1617267.","DOI":"10.1080\/10253890.2019.1617267"},{"key":"4105_CR29","doi-asserted-by":"publisher","unstructured":"Margolis, K.G., Cryan, J.F. and Mayer, E.A. (2021a) \u2018The Microbiota-Gut-Brain Axis: From Motility to Mood\u2019, Gastroenterology, 160(5), p. 1486. Available at: https:\/\/doi.org\/10.1053\/J.GASTRO.2020.10.066.","DOI":"10.1053\/J.GASTRO.2020.10.066"},{"key":"4105_CR30","doi-asserted-by":"publisher","unstructured":"Margolis, K.G., Cryan, J.F. and Mayer, E.A. (2021b) \u2018The Microbiota-Gut-Brain Axis: From Motility to Mood\u2019, Gastroenterology, 160(5), pp. 1486\u20131501. Available at: https:\/\/doi.org\/10.1053\/J.GASTRO.2020.10.066.","DOI":"10.1053\/J.GASTRO.2020.10.066"},{"key":"4105_CR31","doi-asserted-by":"publisher","unstructured":"Matcovitch-Natan, O. et al. (2016) \u2018Microglia development follows a stepwise program to regulate brain homeostasis\u2019, Science (New York, N.Y.), 353(6301). Available at: https:\/\/doi.org\/10.1126\/SCIENCE.AAD8670.","DOI":"10.1126\/SCIENCE.AAD8670"},{"key":"4105_CR32","doi-asserted-by":"publisher","unstructured":"Matheson, J.A.T. and Holsinger, R.M.D. (2023) \u2018The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review\u2019, Int J Mol Sci 2023, Vol. 24, Page 1001, 24(2), p. 1001. Available at: https:\/\/doi.org\/10.3390\/IJMS24021001.","DOI":"10.3390\/IJMS24021001"},{"key":"4105_CR33","doi-asserted-by":"publisher","unstructured":"Metta, V. et al. (2022) \u2018Gastrointestinal dysfunction in Parkinson\u2019s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation\u2019, J neurol, 269(3), pp. 1154\u20131163. Available at: https:\/\/doi.org\/10.1007\/S00415-021-10567-W.","DOI":"10.1007\/S00415-021-10567-W"},{"key":"4105_CR34","doi-asserted-by":"publisher","unstructured":"Mirzaei, H. et al. (2022) \u2018Probiotics and the Treatment of Parkinson\u2019s Disease: An Update\u2019, Cell Molr Neurobiol, 42(8), pp. 2449\u20132457. Available at: https:\/\/doi.org\/10.1007\/S10571-021-01128-W\/METRICS.","DOI":"10.1007\/S10571-021-01128-W\/METRICS"},{"key":"4105_CR35","doi-asserted-by":"publisher","unstructured":"Morais, L.H., Schreiber, H.L. and Mazmanian, S.K. (2021) \u2018The gut microbiota-brain axis in behaviour and brain disorders\u2019, Nature reviews. Microbiol, 19(4), pp. 241\u2013255. Available at: https:\/\/doi.org\/10.1038\/S41579-020-00460-0.","DOI":"10.1038\/S41579-020-00460-0"},{"key":"4105_CR36","doi-asserted-by":"publisher","unstructured":"Nishiwaki, H. et al. (2022) \u2018Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson\u2019s disease\u2019, npj Parkinson\u2019s Disease 2022 8:1, 8(1), pp. 1\u201312. Available at: https:\/\/doi.org\/10.1038\/s41531-022-00328-5.","DOI":"10.1038\/s41531-022-00328-5"},{"key":"4105_CR37","doi-asserted-by":"publisher","unstructured":"Ouzzani, M. et al. (2016) \u2018Rayyan-a web and mobile app for systematic reviews\u2019, Systematic Reviews, 5(1), pp. 1\u201310. Available at: https:\/\/doi.org\/10.1186\/S13643-016-0384-4\/FIGURES\/6.","DOI":"10.1186\/S13643-016-0384-4\/FIGURES\/6"},{"key":"4105_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.N71","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. \u2018The PRISMA 2020 statement: an updated guideline for reporting systematic reviews\u2019, BMJ, 372. Available at: 2021. https:\/\/doi.org\/10.1136\/BMJ.N71.","journal-title":"Available at:"},{"key":"4105_CR39","doi-asserted-by":"publisher","unstructured":"Rekdal, V.M. et al. (2019) \u2018Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism\u2019, Science (New York, N.Y.), 364(6445). Available at: https:\/\/doi.org\/10.1126\/SCIENCE.AAU6323.","DOI":"10.1126\/SCIENCE.AAU6323"},{"key":"4105_CR40","doi-asserted-by":"publisher","unstructured":"Romano, S. et al. (2021) \u2018Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation\u2019, NPJ Parkinson\u2019s Disease, 7(1), p. 27. Available at: https:\/\/doi.org\/10.1038\/S41531-021-00156-Z.","DOI":"10.1038\/S41531-021-00156-Z"},{"key":"4105_CR41","doi-asserted-by":"publisher","unstructured":"Rooks, M.G. and Garrett, W.S. (2016) \u2018Gut microbiota, metabolites and host immunity\u2019, Na rev. Immu, 16(6), pp. 341\u2013352. Available at: https:\/\/doi.org\/10.1038\/NRI.2016.42.","DOI":"10.1038\/NRI.2016.42"},{"key":"4105_CR42","doi-asserted-by":"publisher","unstructured":"Rostagno, A.A. et al. (2023) \u2018The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review\u2019, Int J Mol Sci 2023, Vol. 24, Page 1001, 24(2), p. 1001. Available at: https:\/\/doi.org\/10.3390\/IJMS24021001.","DOI":"10.3390\/IJMS24021001"},{"key":"4105_CR43","doi-asserted-by":"publisher","unstructured":"Scheperjans, F. et al. (2015) \u2018Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype\u2019, Move Dis, 30(3), pp. 350\u2013358. Available at: https:\/\/doi.org\/10.1002\/MDS.26069.","DOI":"10.1002\/MDS.26069"},{"key":"4105_CR44","doi-asserted-by":"publisher","unstructured":"Scheperjans, F. et al. (2024) \u2018Fecal Microbiota Transplantation for Treatment of Parkinson Disease: A Randomized Clinical Trial\u2019, JAMA Neurology, 81(9), pp. 925\u2013938. Available at: https:\/\/doi.org\/10.1001\/jamaneurol.2024.2305.","DOI":"10.1001\/jamaneurol.2024.2305"},{"key":"4105_CR45","doi-asserted-by":"publisher","unstructured":"Segal, A. et al. (2021) \u2018Fecal microbiota transplant as a potential treatment for Parkinson\u2019s disease \u2013 A case series\u2019, Clinical Neurology and Neurosurgery, 207, p. 106791. Available at: https:\/\/doi.org\/10.1016\/J.CLINEURO.2021.106791.","DOI":"10.1016\/J.CLINEURO.2021.106791"},{"key":"4105_CR46","doi-asserted-by":"publisher","unstructured":"Sharon, G. et al. (2016) \u2018The Central Nervous System and the Gut Microbiome\u2019, Cell, 167(4), pp. 915\u2013932. Available at: https:\/\/doi.org\/10.1016\/J.CELL.2016.10.027.","DOI":"10.1016\/J.CELL.2016.10.027"},{"key":"4105_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.L4898","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, et al. \u2018RoB 2: a revised tool for assessing risk of bias in randomised trials\u2019, BMJ, 366. Available at: 2019. https:\/\/doi.org\/10.1136\/BMJ.L4898.","journal-title":"Available at:"},{"key":"4105_CR48","doi-asserted-by":"publisher","unstructured":"Tan, A.H., Lim, S.Y. and Lang, A.E. (2022) \u2018The microbiome\u2013gut\u2013brain axis in Parkinson disease \u2014 from basic research to the clinic\u2019, Nature Reviews Neurology 2022 18:8, 18(8), pp. 476\u2013495. Available at: https:\/\/doi.org\/10.1038\/s41582-022-00681-2.","DOI":"10.1038\/s41582-022-00681-2"},{"key":"4105_CR49","doi-asserted-by":"publisher","unstructured":"Toh, T.S. et al. (2022) \u2018Gut microbiome in Parkinson\u2019s disease: New insights from meta-analysis\u2019, Parkinsonism and Related Disorders, 94, pp. 1\u20139. Available at: https:\/\/doi.org\/10.1016\/j.parkreldis.2021.11.017.","DOI":"10.1016\/j.parkreldis.2021.11.017"},{"key":"4105_CR50","doi-asserted-by":"publisher","unstructured":"Del Tredici, K. and Braak, H. (2008) \u2018A not entirely benign procedure: progression of Parkinson\u2019s disease\u2019, Acta neuropathologica, 115(4), pp. 379\u2013384. Available at: https:\/\/doi.org\/10.1007\/S00401-008-0355-5.","DOI":"10.1007\/S00401-008-0355-5"},{"key":"4105_CR51","doi-asserted-by":"publisher","unstructured":"Verbaan, D. et al. (2007) \u2018Patient-reported autonomic symptoms in Parkinson disease\u2019, Neurology, 69(4), pp. 333\u2013341. Available at: https:\/\/doi.org\/10.1212\/01.WNL.0000266593.50534.E8.","DOI":"10.1212\/01.WNL.0000266593.50534.E8"},{"key":"4105_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0147210","author":"AR Weingarden","year":"2016","unstructured":"Weingarden AR, et al. \u2018Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth\u2019, PloS one, 11(1). Available at: 2016. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0147210.","journal-title":"Available at:"},{"key":"4105_CR53","doi-asserted-by":"publisher","unstructured":"Xie, A. et al. (2022) \u2018Bacterial Butyrate in Parkinson\u2019s Disease Is Linked to Epigenetic Changes and Depressive Symptoms\u2019, Movement Disorders, 37(8), pp. 1644\u20131653. Available at: https:\/\/doi.org\/10.1002\/MDS.29128.","DOI":"10.1002\/MDS.29128"},{"key":"4105_CR54","doi-asserted-by":"publisher","unstructured":"Xue, L.J. et al. (2020) \u2018Fecal microbiota transplantation therapy for Parkinson\u2019s disease: A preliminary study\u2019, Medicine, 99(35), p. E22035. Available at: https:\/\/doi.org\/10.1097\/MD.0000000000022035.","DOI":"10.1097\/MD.0000000000022035"},{"key":"4105_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/S40064-016-2821-1","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Yu YB. \u2018Intestinal microbiota and chronic constipation\u2019, SpringerPlus, 5(1). Available at: 2016. https:\/\/doi.org\/10.1186\/S40064-016-2821-1.","journal-title":"Available at:"},{"key":"4105_CR56","doi-asserted-by":"publisher","unstructured":"Zhao, Z. et al. (2021) \u2018Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis\u2019, Microbiome, 9(1), p. 226. Available at: https:\/\/doi.org\/10.1186\/S40168-021-01107-9.","DOI":"10.1186\/S40168-021-01107-9"},{"key":"4105_CR57","doi-asserted-by":"publisher","unstructured":"Zhu, M. et al. (2022) \u2018Gut Microbiota: A Novel Therapeutic Target for Parkinson\u2019s Disease\u2019, Frontiers in Immunology, 13, p. 937555. Available at: https:\/\/doi.org\/10.3389\/FIMMU.2022.937555.","DOI":"10.3389\/FIMMU.2022.937555"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04105-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04105-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04105-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T03:29:37Z","timestamp":1752722977000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04105-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4105"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04105-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"26 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors\u2019 consent has been obtained by the corresponding author for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"291"}}